Tyra Biosciences Statistics
Total Valuation
TYRA has a market cap or net worth of $736.45 million. The enterprise value is $382.63 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TYRA has 52.60 million shares outstanding. The number of shares has increased by 25.11% in one year.
| Current Share Class | 52.60M |
| Shares Outstanding | 52.60M |
| Shares Change (YoY) | +25.11% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 4.19% |
| Owned by Institutions (%) | 33.86% |
| Float | 23.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.04 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.55, with a Debt / Equity ratio of 0.02.
| Current Ratio | 29.55 |
| Quick Ratio | 29.26 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -28.66% and return on invested capital (ROIC) is -20.96%.
| Return on Equity (ROE) | -28.66% |
| Return on Assets (ROA) | -20.21% |
| Return on Capital (ROIC) | -20.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.71M |
| Employee Count | 49 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.48% in the last 52 weeks. The beta is 1.01, so TYRA's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -1.48% |
| 50-Day Moving Average | 18.06 |
| 200-Day Moving Average | 18.83 |
| Relative Strength Index (RSI) | 32.68 |
| Average Volume (20 Days) | 219,503 |
Short Selling Information
The latest short interest is 2.01 million, so 3.82% of the outstanding shares have been sold short.
| Short Interest | 2.01M |
| Short Previous Month | 1.87M |
| Short % of Shares Out | 3.82% |
| Short % of Float | 8.74% |
| Short Ratio (days to cover) | 4.98 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -100.07M |
| Pretax Income | -80.88M |
| Net Income | -83.74M |
| EBITDA | -99.59M |
| EBIT | -100.07M |
| Earnings Per Share (EPS) | -$1.57 |
Full Income StatementBalance Sheet
The company has $360.13 million in cash and $6.32 million in debt, giving a net cash position of $353.81 million or $6.73 per share.
| Cash & Cash Equivalents | 360.13M |
| Total Debt | 6.32M |
| Net Cash | 353.81M |
| Net Cash Per Share | $6.73 |
| Equity (Book Value) | 362.29M |
| Book Value Per Share | 6.85 |
| Working Capital | 353.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$63.72 million and capital expenditures -$1.26 million, giving a free cash flow of -$64.98 million.
| Operating Cash Flow | -63.72M |
| Capital Expenditures | -1.26M |
| Free Cash Flow | -64.98M |
| FCF Per Share | -$1.24 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |